Home Cart 0 Sign in  

[ CAS No. 321-14-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 321-14-2
Chemical Structure| 321-14-2
Structure of 321-14-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 321-14-2 ]

Related Doc. of [ 321-14-2 ]

Alternatived Products of [ 321-14-2 ]
Product Citations

Product Citations

Tanner J. Schumacher ; Ananth V. Iyer ; Jon Rumbley , et al. DOI:

Abstract: Cancer cells alter their metabolic phenotypes with nutritional change. Single agent approaches targeting mitochondrial metabolism in cancer have failed due to either dose limiting off target toxicities, or lack of efficacy in vivo. To mitigate these clinical challenges, we investigated the potential utility of repurposing FDA approved mitochondrial targeting anthelmintic agents, niclosamide and pyrvinium pamoate, to be combined with GLUT1 inhibitor BAY-876 to enhance the inhibitory capacity of the major metabolic phenotypes exhibited by tumors. To test this, we used breast cancer cell lines MDA-MB-231 and 4T1 which exhibit differing basal metabolic rates of glycolysis and mitochondrial respiration, respectively. Here, we found that specific responses to mitochondrial and glycolysis targeting agents elicit responses that correlate with tested cell lines basal metabolic rates and fuel preference, highlighting the potential to cater metabolism targeting treatment regimens based on specific tumor nutrient handling. Inhibition of GLUT1 with BAY-876 potently inhibited glycolysis in both MDA-MB-231 and 4T1 cells, and niclosamide and pyrvinium pamoate perturbed mitochondrial respiration that resulted in potent compensatory glycolysis in the cell lines tested. In this regard, combination of BAY-876 with both mitochondrial targeting agents resulted in inhibition of compensatory glycolysis and subsequent metabolic crisis. These studies warrant further investigation into targeting tumor metabolism as a combination treatment regimen that can be tailored by basal and compensatory metabolic phenotypes.

Purchased from AmBeed: ;

Product Details of [ 321-14-2 ]

CAS No. :321-14-2 MDL No. :MFCD00002457
Formula : C7H5ClO3 Boiling Point : No data available
Linear Structure Formula :C6H3Cl(OH)(CO2H) InChI Key :NKBASRXWGAGQDP-UHFFFAOYSA-N
M.W : 172.57 Pubchem ID :9447
Synonyms :

Calculated chemistry of [ 321-14-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 40.43
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 3.09
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 1.59
Log Po/w (SILICOS-IT) : 1.38
Consensus Log Po/w : 1.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.19
Solubility : 0.11 mg/ml ; 0.000639 mol/l
Class : Soluble
Log S (Ali) : -3.97
Solubility : 0.0187 mg/ml ; 0.000108 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.81
Solubility : 2.69 mg/ml ; 0.0156 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.18

Safety of [ 321-14-2 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P264-P270-P301+P310+P330-P405-P501 UN#:2811
Hazard Statements:H301 Packing Group:
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 321-14-2 ]

Aryls

Chemical Structure| 56961-31-0

[ 56961-31-0 ]

2-Chloro-6-hydroxybenzoic acid

Similarity: 0.95

Chemical Structure| 4068-78-4

[ 4068-78-4 ]

Methyl 5-chloro-2-hydroxybenzoate

Similarity: 0.93

Chemical Structure| 1829-32-9

[ 1829-32-9 ]

3-Chloro-2-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 320-72-9

[ 320-72-9 ]

3,5-Dichloro-2-hydroxybenzoic acid

Similarity: 0.91

Chemical Structure| 22717-55-1

[ 22717-55-1 ]

Methyl 4-chloro-2-hydroxybenzoate

Similarity: 0.91

Chlorides

Chemical Structure| 56961-31-0

[ 56961-31-0 ]

2-Chloro-6-hydroxybenzoic acid

Similarity: 0.95

Chemical Structure| 4068-78-4

[ 4068-78-4 ]

Methyl 5-chloro-2-hydroxybenzoate

Similarity: 0.93

Chemical Structure| 1829-32-9

[ 1829-32-9 ]

3-Chloro-2-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 320-72-9

[ 320-72-9 ]

3,5-Dichloro-2-hydroxybenzoic acid

Similarity: 0.91

Chemical Structure| 22717-55-1

[ 22717-55-1 ]

Methyl 4-chloro-2-hydroxybenzoate

Similarity: 0.91

Carboxylic Acids

Chemical Structure| 56961-31-0

[ 56961-31-0 ]

2-Chloro-6-hydroxybenzoic acid

Similarity: 0.95

Chemical Structure| 1829-32-9

[ 1829-32-9 ]

3-Chloro-2-hydroxybenzoic acid

Similarity: 0.93

Chemical Structure| 3438-16-2

[ 3438-16-2 ]

5-Chloro-2-methoxybenzoic acid

Similarity: 0.91

Chemical Structure| 320-72-9

[ 320-72-9 ]

3,5-Dichloro-2-hydroxybenzoic acid

Similarity: 0.91

Chemical Structure| 53984-36-4

[ 53984-36-4 ]

3-Chloro-5-hydroxybenzoic acid

Similarity: 0.91

; ;